作者
Zikuan Leng,Rongjia Zhu,Wei Hou,Yingmei Feng,Yanlei Yang,Qin Han,Guangliang Shan,Fanyan Meng,Dongshu Du,Shihua Wang,Junfen Fan,Wenjing Wang,Ling Deng,Hang Shi,Hongjun Li,Zhongjie Hu,Fengchun Zhang,Jinming Gao,Hongjian Liu,Xiaoxia Li,Yangyang Zhao,Kan Yin,Xijing He,Zhixing Gao,Yibin Wang,Bo Yang,Ronghua Jin,Ilia Stambler,Lee Wei Lim,Huanxing Su,Alexey Moskalev,Antonio Rico Cano,Sasanka Chakrabarti,Kyung Jin Min,Georgina M. Ellison‐Hughes,Calogero Caruso,Kunlin Jin,Robert Chunhua Zhao
摘要
A coronavirus (HCoV-19) has caused the novel coronavirus disease (COVID-19) outbreak in Wuhan, China.Preventing and reversing the cytokine storm may be the key to save the patients with severe COVID-19 pneumonia.Mesenchymal stem cells (MSCs) have been shown to possess a comprehensive powerful immunomodulatory function.This study aims to investigate whether MSC transplantation improves the outcome of 7 enrolled patients with COVID-19 pneumonia in Beijing YouAn Hospital, China, from Jan 23, 2020 to Feb